News e-Therapeutics and C4XD research Parkinson's drugs Biotechs search for new treatments for incurable disease
News FDA probes Parkinson's drug safety, Acadia's shares collapse FDA under pressure to act following press reports
News AZ to develop Parkinson's drug with Takeda AstraZeneca could receive up to $400 million from Takeda after approaching the company to jointly develop and market a new treatment for Parkinson’s disease (PD).
News First new Parkinson's treatment in decade gains US approval Newron's Xadago, a new add-on treatment for patients with Parkinson's disease, has been approved by the FDA.
News Precision Neuro breaks new ground in BCI technology Precision Neuroscience has shown that people can control electronic devices with thought alone, without a need for electrodes implanted in the brain.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
